Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

195 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-25

Study Completion Date

2021-05-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Several studies have shown that smokers have a higher risk of developing a severe form of COVID-19 once a person has been infected. This is explained by the damage caused by smoking at the bronchopulmonary level and an overexpression of some coronavirus receptors at the pulmonary level when exposed to tobacco. In contrast, recent data indicate that smokers are proportionally less infected with the COVID-19 virus since all available cohort data from around the world show a very low rate of smokers among COVID-19 infected subjects. The mechanisms at the origin of this protective effect are not known. All of these data lead us to question the real role of nicotine in the protective effect of tobacco observed in the general population against infection by the COVID-19 virus.

The objectives are :

* To show that subjects taking nicotine substitutes as part of a smoking cessation program are less infected with COVID-19 than non-smokers.
* To show that active smokers are less infected with COVID-19 than non-smokers.
* To compare the percentage of positive serological tests in subjects taking nicotine substitutes to the percentage of positive serological tests in active smokers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19)

NCT04583761

COVID-19

COMPLETED

Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19

NCT04403386

COVID-19

COMPLETED

Tobacco Use and COVID-19 Incidence in the Finnish General Population

NCT04915781

SARS-CoV-2 Infection Covid19

COMPLETED

Tobacco Use and the Risk of COVID-19 and Adverse Outcomes

NCT05321433

COVID-19 Respiratory Tract Infections Infections +4 more

COMPLETED

Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes

NCT01681875

Tobacco Dependence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Behaviors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active smokers.

Active smokers since October 2019.

Serological test for COVID-19.

Intervention Type DIAGNOSTIC_TEST

Serological test for COVID-19 performed as part of standard of care.

Smokers undergoing smoking cessation

Smokers undergoing smoking cessation and taking nicotine substitutes on a regular basis since October 2019.

Serological test for COVID-19.

Intervention Type DIAGNOSTIC_TEST

Serological test for COVID-19 performed as part of standard of care.

Non-smoking.

Person who's never smoked before.

Serological test for COVID-19.

Intervention Type DIAGNOSTIC_TEST

Serological test for COVID-19 performed as part of standard of care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Serological test for COVID-19.

Serological test for COVID-19 performed as part of standard of care.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years old
* Subject who will require a serological test for COVID-19 virus as part of standard of care.
* Group 1: Active smoker since October 2019
* Group 2: Smoker undergoing smoking cessation and taking nicotine substitutes on a regular basis since October 2019
* Group 3: Non-smoker